ANG Lifesciences Valuation

<div class='circular--portrait' style='background:#006400;color: #FFE4E1;font-size:4em;padding-top: 25px;;'>AL</div>
What is the current enterprise value of ANG Lifesciences India? ANG Lifesciences India prevailing Real Value cannot be determined due to lack of data. The current price of ANG Lifesciences India is 0.0. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Our model approximates the value of ANG Lifesciences India from examining the firm fundamentals such as current valuation of 310.94 M, return on equity of 21.75 %, and profit margin of 4.64 % as well as evaluating its technical indicators and Probability Of Bankruptcy. In general, we favor picking up undervalued instruments and discarding overvalued instruments since, in the future, asset prices and their ongoing real values will blend.

Search Valuation

 
Refresh
ANG Lifesciences Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as ANG Lifesciences's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.

ANG Lifesciences Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining ANG Lifesciences's current stock value. Our valuation model uses many indicators to compare ANG Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ANG Lifesciences competition to find correlations between indicators driving ANG Lifesciences's intrinsic value. More Info.
ANG Lifesciences India is number one stock in price to book category among related companies. It is number one stock in price to sales category among related companies fabricating about  0.23  of Price to Sales per Price to Book. The ratio of Price to Book to Price to Sales for ANG Lifesciences India is roughly  4.38 
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Trending Equities. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page